# Provention Bio (stock symbol: PRVB) Logo in transparent PNG and SVG formats

## Provention Bio Logo large

### Provention Bio Logo large Download PNG (30.58 KB)

![Provention Bio Logo large Download PNG (30.58 KB)](/img/orig/PRVB_BIG-c0b1dac8.png)

### Provention Bio Logo large Download SVG (8.34 KB)

![Provention Bio Logo large Download SVG (8.34 KB)](/img/orig/PRVB_BIG-9a4a4992.svg)

## Provention Bio Logo icon format

### Provention Bio Logo icon format Download PNG (64.94 KB)

![Provention Bio Logo icon format Download PNG (64.94 KB)](/img/orig/PRVB-8b26604b.png)

### Provention Bio Logo icon format Download SVG (3.45 KB)

![Provention Bio Logo icon format Download SVG (3.45 KB)](/img/orig/PRVB-c88c51ea.svg)

## Provention Bio Logo large for dark backgrounds

### Provention Bio Logo large for dark backgrounds Download PNG (19.99 KB)

![Provention Bio Logo large for dark backgrounds Download PNG (19.99 KB)](/img/orig/PRVB_BIG.D-51bd7910.png)

### Provention Bio Logo large for dark backgrounds Download SVG (8.26 KB)

![Provention Bio Logo large for dark backgrounds Download SVG (8.26 KB)](/img/orig/PRVB_BIG.D-bb92250e.svg)

## Provention Bio Logo icon format for dark backgrounds

### Provention Bio Logo icon format for dark backgrounds Download PNG (37.89 KB)

![Provention Bio Logo icon format for dark backgrounds Download PNG (37.89 KB)](/img/orig/PRVB.D-1ff78a6c.png)

### Provention Bio Logo icon format for dark backgrounds Download SVG (3.37 KB)

![Provention Bio Logo icon format for dark backgrounds Download SVG (3.37 KB)](/img/orig/PRVB.D-519193ec.svg)

## About Provention Bio

Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.

1. Website domain: proventionbio.com
2. Employees: 82
3. Marketcap: $2.37 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
